A detailed history of Evernest Financial Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evernest Financial Advisors, LLC holds 4,596 shares of LLY stock, worth $4.16 Million. This represents 1.58% of its overall portfolio holdings.

Number of Shares
4,596
Previous 4,483 2.52%
Holding current value
$4.16 Million
Previous $3.32 Billion 0.59%
% of portfolio
1.58%
Previous 1.72%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $66,918 - $89,527
113 Added 2.52%
4,596 $3.34 Billion
Q4 2023

May 10, 2024

SELL
$525.19 - $619.13 $66,699 - $78,629
-127 Reduced 2.76%
4,469 $2.61 Billion
Q4 2021

Feb 13, 2024

BUY
$224.85 - $279.04 $1.01 Million - $1.25 Million
4,483 New
4,483 $3.32 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $860B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Evernest Financial Advisors, LLC Portfolio

Follow Evernest Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evernest Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evernest Financial Advisors, LLC with notifications on news.